Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 241 AL 255

The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3 × Tg-AD) mouse model strain

Tian S, Ye T, Cheng X.

Exp Neurol. 2023 Oct;368:114505. doi: 10.1016/j.expneurol.2023.114505. Epub 2023 Aug 18.

Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology

Lau SF, Fu AKY, Ip NY.

J Neurochem. 2023 Sep;166(6):891-903. doi: 10.1111/jnc.15933. Epub 2023 Aug 21.

New treatments for Alzheimer's disease

Howard R, Kales HC.

BMJ. 2023 Aug 22;382:1852. doi: 10.1136/bmj.p1852.

An inclusive study of recent advancements in Alzheimer's disease: A comprehensive review

Singh S, Mahajan M, Kumar D, Singh K, Chowdhary M, Amit.

Neuropeptides. 2023 Dec;102:102369. doi: 10.1016/j.npep.2023.102369. Epub 2023 Aug 12.

Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease

Aili M, Zhou K, Zhan J, Zheng H, Luo F.

J Mater Chem B. 2023 Sep 20;11(36):8605-8621. doi: 10.1039/d3tb01023f.

The tauopathies

Devi G.

Handb Clin Neurol. 2023;196:251-265. doi: 10.1016/B978-0-323-98817-9.00015-6.

Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism

Hu J, Zheng L, Guan Z, Zhong K, Huang F, Huang Q, Yang J, Li W, Li S.

Brain Res Bull. 2023 Oct 1;202:110750. doi: 10.1016/j.brainresbull.2023.110750. Epub 2023 Aug 23.

A New Perspective for the Treatment of Alzheimer's Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies

Ribeiro J, Lopes I, Gomes AC.

Molecules. 2023 Aug 11;28(16):6015. doi: 10.3390/molecules28166015.

Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease

Pati S, Singh Gautam A, Dey M, Tiwari A, Kumar Singh R.

Drug Discov Today. 2023 Dec;28(12):103750. doi: 10.1016/j.drudis.2023.103750. Epub 2023 Aug 24.

Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test

Costa T, Premi E, Liloia D, Cauda F, Manuello J.

J Alzheimers Dis. 2023;95(3):1059-1065. doi: 10.3233/JAD-230589.

Management of neuropsychiatric symptoms in dementia

Devanand DP.

Curr Opin Neurol. 2023 Oct 1;36(5):498-503. doi: 10.1097/WCO.0000000000001199. Epub 2023 Aug 7.

Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain

Edland SD, Llibre-Guerra JJ.

Neurology. 2023 Oct 3;101(14):593-594. doi: 10.1212/WNL.0000000000207861. Epub 2023 Aug 29.

Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury

Sridharan PS, Miller E, Pieper AA.

Neurotherapeutics. 2023 Oct;20(6):1616-1628. doi: 10.1007/s13311-023-01427-8. Epub 2023 Aug 31.

Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological properties

Liu J, Li T, Zhong G, Pan Y, Gao M, Su S, Liang Y, Ma C, Liu Y, Wang Q, Shi Q.

Biomed Pharmacother. 2023 Oct;166:115406. doi: 10.1016/j.biopha.2023.115406. Epub 2023 Sep 4.

Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective

Bandakinda M, Mishra A.

Int J Biol Macromol. 2023 Dec 31;253(Pt 1):126561. doi: 10.1016/j.ijbiomac.2023.126561. Epub 2023 Sep 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias